167 related articles for article (PubMed ID: 12052002)
1. Analysis of solvent central nervous system toxicity and ethanol interactions using a human population physiologically based kinetic and dynamic model.
MacDonald AJ; Rostami-Hodjegan A; Tucker GT; Linkens DA
Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):165-76. PubMed ID: 12052002
[TBL] [Abstract][Full Text] [Related]
2. A comparison of physiologically based pharmacokinetic model predictions and experimental data for inhaled ethanol in male and female B6C3F1 mice, F344 rats, and humans.
Pastino GM; Asgharian B; Roberts K; Medinsky MA; Bond JA
Toxicol Appl Pharmacol; 1997 Jul; 145(1):147-57. PubMed ID: 9221833
[TBL] [Abstract][Full Text] [Related]
3. Occupational exposure limits in the context of solvent mixtures, consumption of ethanol, and target tissue dose.
Dennison JE; Bigelow PL; Andersen ME
Toxicol Ind Health; 2004 Sep; 20(6-10):165-75. PubMed ID: 15941013
[TBL] [Abstract][Full Text] [Related]
4. Physiologically-based pharmacokinetic modeling of a mixture of toluene and xylene in humans.
Tardif R; Laparé S; Charest-Tardif G; Brodeur J; Krishnan K
Risk Anal; 1995 Jun; 15(3):335-42. PubMed ID: 7604167
[TBL] [Abstract][Full Text] [Related]
5. Human inhalation exposures to toluene, ethylbenzene, and m-xylene and physiologically based pharmacokinetic modeling of exposure biomarkers in exhaled air, blood, and urine.
Marchand A; Aranda-Rodriguez R; Tardif R; Nong A; Haddad S
Toxicol Sci; 2015 Apr; 144(2):414-24. PubMed ID: 25601989
[TBL] [Abstract][Full Text] [Related]
6. Proposed occupational exposure limits for select ethylene glycol ethers using PBPK models and Monte Carlo simulations.
Sweeney LM; Tyler TR; Kirman CR; Corley RA; Reitz RH; Paustenbach DJ; Holson JF; Whorton MD; Thompson KM; Gargas ML
Toxicol Sci; 2001 Jul; 62(1):124-39. PubMed ID: 11399800
[TBL] [Abstract][Full Text] [Related]
7. Assessing human variability in kinetics for exposures to multiple environmental chemicals: a physiologically based pharmacokinetic modeling case study with dichloromethane, benzene, toluene, ethylbenzene, and m-xylene.
Valcke M; Haddad S
J Toxicol Environ Health A; 2015; 78(7):409-31. PubMed ID: 25785556
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of potential toxicity from co-exposure to three CNS depressants (toluene, ethylbenzene, and xylene) under resting and working conditions using PBPK modeling.
Dennison JE; Bigelow PL; Mumtaz MM; Andersen ME; Dobrev ID; Yang RS
J Occup Environ Hyg; 2005 Mar; 2(3):127-35. PubMed ID: 15764536
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of rat respiratory-tract cytochrome P-450 activity after acute low-level m-xylene inhalation: role in 1-nitronaphthalene toxicity.
Foy JW; Schatz RA
Inhal Toxicol; 2004 Mar; 16(3):125-32. PubMed ID: 15204773
[TBL] [Abstract][Full Text] [Related]
10. Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.
Marino DJ; Starr TB
Regul Toxicol Pharmacol; 2007 Dec; 49(3):285-300. PubMed ID: 17949874
[TBL] [Abstract][Full Text] [Related]
11. m-xylene toxicokinetics in phenobarbital-treated rats: comparison among inhalation exposure, oral administration, and intraperitoneal administration.
Kaneko T; Wang PY; Tsukada H; Sato A
Toxicol Appl Pharmacol; 1995 Mar; 131(1):13-20. PubMed ID: 7878667
[TBL] [Abstract][Full Text] [Related]
12. Combining physiologically based pharmacokinetic modeling with Monte Carlo simulation to derive an acute inhalation guidance value for trichloroethylene.
Simon TW
Regul Toxicol Pharmacol; 1997 Dec; 26(3):257-70. PubMed ID: 9441916
[TBL] [Abstract][Full Text] [Related]
13. Ethanol induced modification of m-xylene toxicokinetics in humans.
Tardif R; Sato A; Laparé S; Brodeur J
Occup Environ Med; 1994 Mar; 51(3):187-91. PubMed ID: 8130847
[TBL] [Abstract][Full Text] [Related]
14. Effect of a single administration of benzene, toluene or m-xylene on carboxyhaemoglobin elevation and metabolism of dichloromethane in rats.
Kim SK; Kim YC
J Appl Toxicol; 1996; 16(5):437-44. PubMed ID: 8889796
[TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans.
Tardif R; Charest-Tardif G; Brodeur J; Krishnan K
Toxicol Appl Pharmacol; 1997 May; 144(1):120-34. PubMed ID: 9169076
[TBL] [Abstract][Full Text] [Related]
16. Enzyme induction by ethanol consumption affects the pharmacokinetics of inhaled m-xylene only at high levels of exposure.
Kaneko T; Wang PY; Sato A
Arch Toxicol; 1993; 67(7):473-7. PubMed ID: 8239996
[TBL] [Abstract][Full Text] [Related]
17. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene.
Nong A; McCarver DG; Hines RN; Krishnan K
Toxicol Appl Pharmacol; 2006 Jul; 214(1):78-87. PubMed ID: 16464483
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the dermal absorption of m-xylene vapor in humans using breath sampling and physiologically based pharmacokinetic analysis.
Loizou GD; Jones K; Akrill P; Dyne D; Cocker J
Toxicol Sci; 1999 Apr; 48(2):170-9. PubMed ID: 10353308
[TBL] [Abstract][Full Text] [Related]
19. Combined exposure to m-xylene and ethanol: oxidative stress in the rat liver.
Jajte J; Stetkiewicz J; Wrońska-Nofer T
Int J Occup Med Environ Health; 2003; 16(4):345-50. PubMed ID: 14964644
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the dermal bioavailability of aqueous xylene in F344 rats and human volunteers.
Thrall K; Woodstock A
J Toxicol Environ Health A; 2003 Jul; 66(13):1267-81. PubMed ID: 12851123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
